Watch Virginia This Morning each weekday from 9 to 10 a.m. Find the show on Facebook and Instagram at @VirginiaThisMorning.

Victorian brain cancer researchers have achieved a global-first, using an innovative process to learn how a new drug suppresses tumor activity and provides hope to patients with low-grade gliomas (LGG ...

Art Sullivan, a 38-year-old Ironman athlete, and Josh Lehman, 48, who works at the University of Rochester, are connected by an unlikely foe: a type of brain tumor called an astrocytoma that tends to ...

As a fully volunteer-based organization, Brain Cancer Canada ensures that every dollar raised is maximized toward critical research investments. Since 2015, it has directed nearly $3 million to brain ...

Researchers have identified a vitamin B12–based compound that appears capable of crossing the blood–brain barrier and ...

The treatment resulted in around 20% of the patients who received it living more than five years, compared to nine months in the control group. (Jonathan Park / Daily Trojan file photo) Keck Medicine ...

Chinese Medical Journals Publishing House Co., Ltd. Brain cancer is one of the most aggressive and life-threatening diseases, with glioblastoma (GBM) being the most common and deadliest type. Patients ...

Oligodendroglioma is a rare type of brain tumor. It’s in a category of brain and spinal cord tumors called gliomas. These are brain or spinal cord tumors that come from abnormal glial cells, the ...

An AI model trained on over 30,000 tumors from 10 different solid cancer types aims to turn complex mutation information into ...

The results of the trial will be presented during the American Society of Clinical Oncology annual meeting in Chicago ...

Brain Cancer Canada (BCC), the country’s only 100% volunteer-driven charity dedicated exclusively to funding brain cancer research nationwide, is proud to award $50,000 through the Dwayne Andrews ...

It was a little less than a year ago when a 16-year-old Fremd High School student got the diagnosis that he had a rare and ...